BioStock: One-on-one with Annexin Pharmaceuticals' new CFO

Biotech company Annexin Pharmaceuticals has had intensive months with the phase II study in RVO as well as investments in the cancer area. Most recently, the company announced that it had recruited Susanne Andersson as the new CFO and as part of the management team. BioStock spoke to Susanne in connection with her appointment today, to learn more about her background and expectations for the role at Annexin.

Read the interview with Annexin Pharmaceuticals' new CFO Susanne Andersson here:

https://www.biostock.se/en/2023/04/one-on-one-with-annexin-pharmaceuticals-new-cfo/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/